On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...